AngioDynamics prices secondary offering
Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy
AngioDynamics Inc. priced a secondary offering of 2.35 million shares at $16.20 apiece.
The stocks will be sold by certain shareholders of the company and AngioDynamics will not receive any proceeds from the sale.
Barclays Capital Inc. is acting as the sole underwriter for the offering.